Federated Hermes, Inc. Ovid Therapeutics Inc. Transaction History

Federated Hermes, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$2.65 - $3.49 $5,000 - $6,585	-1,887 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.13 - $3.73 $2,053 - $2,446	656 Added 53.29%	1,887 $6,000
Q3 2021 Nov 15, 2021	BUY	$3.31 - $4.04 $3,247 - $3,963	981 Added 392.4%	1,231 $4,000
Q2 2021 Aug 16, 2021	BUY	$3.3 - $4.49 $825 - $1,122	250 New	250 $1,000
Q1 2021 May 13, 2021	SELL	$2.42 - $4.47 $1,168 - $2,159	-483 Closed	0 $0

Q4 2020 Feb 12, 2021	SELL	$2.28 - $6.84 $4,046 - $12,141	-1,775 Reduced 78.61%	483 $1,000
Q3 2020 Nov 12, 2020	BUY	$5.39 - $8.24 $10,979 - $16,784	2,037 Added 921.72%	2,258 $13,000
Q2 2020 Aug 13, 2020	SELL	$2.67 - $7.91 $2 - $7	-1 Reduced 0.45%	221 $2,000
Q1 2020 May 13, 2020	SELL	$2.03 - $4.35 $198 - $426	-98 Reduced 30.63%	222 $1,000
Q4 2019 Feb 14, 2020	BUY	$2.08 - $5.06 $665 - $1,619	320 New	320 $1,000

43.2M

5.9K

300

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $52.8M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.